Statistics
Publications
13
Citations
1.8K
H-Index
10
Active since
1984
Affiliations
Eli Lilly (United States)(Current)
Douglas J. Zeckner is an author at Eli Lilly (United States) specializing in antifungal agents, drug discovery, and antifungal pharmacology.
Publications per year
1984–2016
13
13
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten, Andrew L. Faber, Candice L. Horn et al. · Nature · 2007 · 1.3K citations
Manuel Debono, William W. Turner, Lisa LaGrandeur et al. · Journal of Medicinal Chemistry · 1995 · 113 citations
In vitro and in vivo anti-Candida activity and toxicology of LY121019.
Robert S. Gordee, Douglas J. Zeckner, L. F. Ellis et al. · The Journal of Antibiotics · 1984 · 109 citations · Full text
1–5 of 13